Differential effects of Epigallocatechin‐3‐gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model

Abstract

This work suggests that the dose of EGCG and composition of EGCG-containing supplements may be important in correcting skeletal deficits associated with DS. Careful analyses of these parameters may lead to a better understanding of how to improve skeletal and other deficits that impair individuals with DS.